Metipranolol
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
Trade names | Optipranolol |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601078 |
ATC code | S01ED04 (WHO) C07BA68 (WHO) |
Identifiers | |
|
|
CAS Number | 22664-55-7 |
PubChem (CID) | 31477 |
IUPHAR/BPS | 7239 |
DrugBank | DB01214 |
ChemSpider | 29193 |
UNII | X39AL81KEB |
KEGG | D02374 |
ChEMBL | CHEMBL1291 |
ECHA InfoCard | 100.041.031 |
Chemical and physical data | |
Formula | C17H27NO4 |
Molar mass | 309.401 g/mol |
3D model (Jmol) | Interactive image |
Chirality | Racemic mixture |
|
|
|
|
(verify) |
Metipranolol (OptiPranolol, Betanol, Disorat, Trimepranol) is a non-selective beta blocker used in eye drops to treat glaucoma. It is rapidly metabolized into desacetylmetipranolol.[1]
References[edit]
- ^ Maffei Facino, R.; Bertuletti, R.; Carini, M.; Tofanetti, O. (1980). "In vitro metabolism of methypranolol by rat liver". Analytical Chemistry Symposia Series. 4 (6): 217–223.
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |